FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Grant Hoyt

Research Profile

Procedures

Living Beings

Physiology

Chemicals & Drugs

Anatomy

Myocardium

Disorders

Co-author Network

Publications

TOP 3
Leora B Balsam; Golnaz K Mokhtari; Sophie Jones; Shannon Peterson; E Grant Hoyt; Theo Kofidis; Masashi Tanaka; David T Cooke; Robert C Robbins
Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease.
David T Cooke; E Grant Hoyt; Robert C Robbins
Overexpression of human Bcl-2 in syngeneic rat donor lungs preserves posttransplant function and reduces intragraft caspase activity and interleukin-1beta production.
Maarten A Lijkwan; David T Cooke; Jasper M Martens; Murray H Kown; Seiichiro Murata; Shannon H Peterson; E Grant Hoyt; Robert C Robbins
Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Grant Hoyt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Leora B Balsam; Golnaz K Mokhtari; Sophie Jones; Shannon Peterson; E Grant Hoyt; Theo Kofidis; Masashi Tanaka; David T Cooke; Robert C Robbins
Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(7):827-32.
2005: David T Cooke; E Grant Hoyt; Robert C Robbins
Overexpression of human Bcl-2 in syngeneic rat donor lungs preserves posttransplant function and reduces intragraft caspase activity and interleukin-1beta production.
Transplantation 2005;79(7):762-7.
2005: Maarten A Lijkwan; David T Cooke; Jasper M Martens; Murray H Kown; Seiichiro Murata; Shannon H Peterson; E Grant Hoyt; Robert C Robbins
Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(4):439-45.
2003: Douglas N Miniati; Maarten A Lijkwan; Seiichiro Murata; Jasper Martens; Caroline T Coleman; E Grant Hoyt; Robert C Robbins
Effects of adenoviral up-regulation of bcl-2 on oxidative stress and graft coronary artery disease in rat heart transplants.
Transplantation 2003;76(2):382-6.
2002: Atsushi Yamaguchi; Douglas N Miniati; Ken ichi Hirata; E Grant Hoyt; Robert C Robbins
Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2002;21(4):417-24.
2002: Jürg Grünenfelder; Douglas N Miniati; Seiichiro Murata; Volkmar Falk; E Grant Hoyt; Robert C Robbins
Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-beta1 ameliorates ischemia-reperfusion injury in rat cardiac allografts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2002;21(2):244-50.
2001: Jürg Grünenfelder; Douglas N Miniati; Seiichiro Murata; Volkmar Falk; E Grant Hoyt; Murray H Kown; Mark L Koransky; Robert C Robbins
Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts.
Circulation 2001;104(12 Suppl 1):I202-6.
2000: BT Feeley; Douglas N Miniati; AK Park; E Grant Hoyt; Robert C Robbins
Nuclear factor-kappaB transcription factor decoy treatment inhibits graft coronary artery disease after cardiac transplantation in rodents.
Transplantation 2000;70(11):1560-8.
2000: Douglas N Miniati; E Grant Hoyt; BT Feeley; Robert S Poston; Robert C Robbins
Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease.
Circulation 2000;102(19 Suppl 3):III237-42.
2000: BT Feeley; Robert S Poston; AK Park; MP Ennen; E Grant Hoyt; Patrick W Vriens; Robert C Robbins
Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts.
Transplantation 2000;69(6):1067-74.
1999: BT Feeley; AK Park; E Grant Hoyt; Robert C Robbins
Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1999;18(11):1088-95.
1999: Robert S Poston; D J Ing; MP Ennen; E Grant Hoyt; Robert C Robbins
ICAM-1 affects reperfusion injury and graft function after cardiac transplantation.
The Journal of surgical research 1999;87(1):25-31.
1999: Robert S Poston; Michael J Mann; E Grant Hoyt; MP Ennen; Victor J Dzau; Robert C Robbins
Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method.
Transplantation 1999;68(6):825-32.
1999: Robert S Poston; Margaret E Billingham; E Grant Hoyt; J Pollard; Randi Shorthouse; randall morris; Robert C Robbins
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
Circulation 1999;100(1):67-74.
1999: BT Feeley; AK Park; S Alexopoulos; E Grant Hoyt; MP Ennen; Robert S Poston; Robert C Robbins
Pressure delivery of AS-ICAM-1 ODN with LFA-1 mAb reduces reperfusion injury in cardiac allografts.
The Annals of thoracic surgery 1999;68(1):119-24.
1999: Michael J Mann; Gary H Gibbons; H Hutchinson; Robert S Poston; E Grant Hoyt; Robert C Robbins; Victor J Dzau
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(11):6411-6.
1998: Robert S Poston; MP Ennen; J Pollard; E Grant Hoyt; Margaret E Billingham; Robert C Robbins
Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts.
The Journal of thoracic and cardiovascular surgery 1998;116(3):386-96.
1998: Robert S Poston; K P Tran; Michael J Mann; E Grant Hoyt; Victor J Dzau; Robert C Robbins
Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1998;17(4):349-55.
1997: Robert S Poston; Margaret E Billingham; J Pollard; E Grant Hoyt; Robert C Robbins
Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease.
The Annals of thoracic surgery 1997;64(4):1004-12.
1995: S J Nisco; R J Hissink; P W Vriens; E Grant Hoyt; Bruce A Reitz; Carol Clayberger
In vivo studies of the maintenance of peripheral transplant tolerance after cyclosporine. Radiosensitive antigen-specific suppressor cells mediate lasting graft protection against primed effector cells.
Transplantation 1995;59(10):1444-52.
1994: P W Vriens; S J Nisco; E Grant Hoyt; Shu-Chen Lyu; P Pierre; Bruce A Reitz; Carol Clayberger
Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
Transplantation 1994;57(12):1795-8.
1992: M Kitamura; Gerald J Berry; Margaret E Billingham; E Grant Hoyt; J Gutierrez; Carol Clayberger; Vaughn A Starnes
Assessment of cardiac allograft rejection with electrophysiology of the conduction system and histopathology of the ventricle.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1992;11(2 Pt 1):280-8.
1991: T Flavin; K Ivens; J Wang; J Gutierrez; E Grant Hoyt; Margaret E Billingham; randall morris
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.
Transplantation proceedings 1991;23(1 Pt 1):531-2.
1990: T Flavin; Judith A Shizuru; Karl Boynton Seydel; A Wu; N Fujimoto; E Grant Hoyt; K Ivens; Margaret E Billingham; C Garrison Fathman; Vaughn A Starnes
Selective T-cell depletion with Ox-38 anti-CD4 monoclonal antibody prevents cardiac allograft rejection in rats.
The Journal of heart transplantation 1990;9(5):482-8.
1990: randall morris; E Grant Hoyt; M P Murphy; E M Eugui; A C Allison
Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.
Transplantation proceedings 1990;22(4):1659-62.
1989: randall morris; E Grant Hoyt; M P Murphy; Randi Shorthouse
Immunopharmacology of FK-506.
Transplantation proceedings 1989;21(1 Pt 1):1042-4.
1988: R C Hagberg; E Grant Hoyt; Margaret E Billingham; R K Sibley; Vaughn A Starnes; J C Baldwin
Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
The Journal of heart transplantation 1988;7(5):359-69.
1988: E Grant Hoyt; R C Hagberg; Margaret E Billingham; J C Baldwin; S W Jamieson
Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G.
The Journal of heart transplantation 1988;7(2):111-7.